Utility of Prognostic Markers in Second-line Treatment of Metastatic Urothelial Cancer

S. E.M. Raby; R. Conroy; J. Lyons; J. Weaver; T. Elliott; A. Choudhury

doi:10.1016/j.clon.2017.07.015

Utility of Prognostic Markers in Second-line Treatment of Metastatic Urothelial Cancer

S. E.M. Raby, R. Conroy, J. Lyons, J. Weaver, T. Elliott, A. Choudhury

Division of Cancer Sciences (L5)

Manchester Academic Health Science Centre (MAHSC)

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e206
Journal	Clinical Oncology
Volume	29
Issue number	11
Early online date	19 Aug 2017
DOIs	https://doi.org/10.1016/j.clon.2017.07.015
Publication status	Published - 1 Nov 2017

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.clon.2017.07.015

Cite this

@article{c0ab035fdce34ce3953a52a3c20e3c3e,

title = "Utility of Prognostic Markers in Second-line Treatment of Metastatic Urothelial Cancer",

author = "Raby, {S. E.M.} and R. Conroy and J. Lyons and J. Weaver and T. Elliott and A. Choudhury",

year = "2017",

month = nov,

day = "1",

doi = "10.1016/j.clon.2017.07.015",

language = "English",

volume = "29",

pages = "e206",

journal = "Clinical Oncology",

issn = "0936-6555",

publisher = "W.B. Saunders Co. Ltd",

number = "11",

}

TY - JOUR

T1 - Utility of Prognostic Markers in Second-line Treatment of Metastatic Urothelial Cancer

AU - Raby, S. E.M.

AU - Conroy, R.

AU - Lyons, J.

AU - Weaver, J.

AU - Elliott, T.

AU - Choudhury, A.

PY - 2017/11/1

Y1 - 2017/11/1

U2 - 10.1016/j.clon.2017.07.015

DO - 10.1016/j.clon.2017.07.015

M3 - Letter

AN - SCOPUS:85027726411

SN - 0936-6555

VL - 29

SP - e206

JO - Clinical Oncology

JF - Clinical Oncology

IS - 11

ER -